BridgeBio Pharma

-$0.07 (-0.18%) As of 3:44 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BBIO and other ETFs, options, and stocks.

About BBIO

BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development.

CEO
Neil Kumar
Employees
385
Headquarters
Palo Alto, California
Founded
2015

BBIO Key Statistics

Market cap
5.86B
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.04M
High today
$40.16
Low today
$39.31
Open price
$39.84
Volume
59.83K
52 Week high
$73.50
52 Week low
$37.64

BBIO Earnings

-$1.18
-$0.79
-$0.39
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Feb 24, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure